GPR68 and glioblastoma: It effectively inhibits GPR68 activity at concentrations as low as 0.5–2 μM in cell models of glioblastoma, where it also induces ferroptotic cell death across a variety of glioblastoma lines, including those resistant to standard chemotherapy like temozolomide19.